AVBP - ArriVent BioPharma, Inc. Common Stock
ArriVent BioPharma, Inc. Common Stock Logo

AVBP - ArriVent BioPharma, Inc. Common Stock

https://arrivent.com
Hold Momentum: Bearish
Recent News
Powered by Alpha Vantage
Bullish
This Microsoft Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Amentum Holdings ( NYSE:AMTM ) , ArriVent BioPharma ( NASDAQ:AVBP )
Benzinga • 5 months, 3 weeks ago • score: 0.28
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. B. Riley Securities analyst Kalpit Patel initiated coverage on ArriVent BioPharma, Inc.
AI Tools
Key Metrics
Trend: Downtrend
As of 2025-09-10 (Snapshot)

None

52W High
$36.37
52W Low
$15.47
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
N/A
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
N/A
EV/Revenue (<3 favorable)
N/A
P/S (TTM) (<3 favorable)
N/A
P/B (<3 favorable)
3.28
Ownership
Institution‑heavy
Source: Overview
Insiders (1–5% typical)
8.24%
Institutions (25–75% balanced)
83.06%
Shares Outstanding
40,568,900
Float
21,604,200
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
0
Gross Profit (TTM)
0
EPS (TTM)
-4.00
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
N/A
ROE (TTM) (>15% strong)
-0.50%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
N/A
Momentum
Bearish momentum
Value
-0.1008
Previous
-0.0490
Trend
Falling
Signal Cross
No cross
As of
Sep. 11, 2025